Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANKRD23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
SPSB3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GSE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS9D1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2J1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NHSL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MCRIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STXBP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APOPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EML4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
G6PC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTENP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SETDB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NADK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ATG2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAPK9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZMYM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on